Hennion & Walsh Asset Management, Inc.
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 1861642
Parsippany, NJ
Position in IOVA
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$3,406,678
+$1,969,460 QoQ
Shares Held
818,913
+100.0% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#2
of 9 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $200,308,891 across 60 Biotechnology names. IOVA ranks #29 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
48,019 | $11,571,138 | |
| 2 | CELC |
Celcuity Inc.
|
100,368 | $10,500,500 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
276,696 | $10,182,412 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
171,470 | $9,741,210 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
342,883 | $7,495,422 | |
| 6 | QURE |
uniQure N.V.
|
142,113 | $6,545,724 | |
| 7 | KURA |
Kura Oncology, Inc.
|
568,845 | $6,240,229 | |
| 8 | ARDX |
Ardelyx, Inc.
|
1,211,690 | $6,179,619 |
All Filings in IOVA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,406,678 | 818,913 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,437,218 | 409,464 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,119,862 | 410,206 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,181,246 | 544,353 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $858,713 | 499,252 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,221,360 | 366,775 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,486,259 | 335,981 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,300,106 | 351,449 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,952,579 | 368,152 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $6,038,097 | 407,429 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,325,456 | 286,034 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $821,252 | 180,495 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,277,978 | 181,531 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,102,781 | 180,488 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,083,143 | 169,506 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $883,783 | 92,253 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $927,580 | 84,020 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $811,138 | 48,717 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $562,811 | 29,482 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||